Polo-like kinase 1 promotes pulmonary hypertension

Respir Res. 2023 Aug 19;24(1):204. doi: 10.1186/s12931-023-02498-z.

Abstract

Background: Pulmonary hypertension (PH) is a lethal vascular disease with limited therapeutic options. The mechanistic connections between alveolar hypoxia and PH are not well understood. The aim of this study was to investigate the role of mitotic regulator Polo-like kinase 1 (PLK1) in PH development.

Methods: Mouse lungs along with human pulmonary arterial smooth muscle cells and endothelial cells were used to investigate the effects of hypoxia on PLK1. Hypoxia- or Sugen5416/hypoxia was applied to induce PH in mice. Plk1 heterozygous knockout mice and PLK1 inhibitors (BI 2536 and BI 6727)-treated mice were checked for the significance of PLK1 in the development of PH.

Results: Hypoxia stimulated PLK1 expression through induction of HIF1α and RELA. Mice with heterozygous deletion of Plk1 were partially resistant to hypoxia-induced PH. PLK1 inhibitors ameliorated PH in mice.

Conclusions: Augmented PLK1 is essential for the development of PH and is a druggable target for PH.

Keywords: HIF1α; Hypoxia; Polo-like kinase 1; Pulmonary hypertension; RELA/p65.

MeSH terms

  • Animals
  • Cell Cycle Proteins / genetics
  • Endothelial Cells
  • Humans
  • Hypertension, Pulmonary* / genetics
  • Hypoxia
  • Mice
  • Mice, Knockout
  • Polo-Like Kinase 1

Substances

  • Cell Cycle Proteins